fbpx

Cure Parkinson’s

18 results.

September 29, 2023 2023 Tom Isaacs Award honors Dr. Natasha Fothergill-Misbah

GRAND RAPIDS (Mich.) Sept. 29, 2023 — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr. Natasha Fothergill-Misbah, Research…

August 28, 2023 Preliminary phase 2 trial results of lixisenatide presented

Copenhagen, Denmark (August 28, 2023) — A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate…

March 13, 2023 Van Andel Institute, Cure Parkinson’s renew $4.5 million co-funding agreement to support collaborative Parkinson’s clinical trials program

Grand Rapids, Mich. (March 13, 2023) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce that their co-funding agreement, which supports…

March 19, 2021 New uses for existing medications provide hope for Parkinson’s disease breakthroughs

Drug repurposing program seeks to find treatments that slow or stop Parkinson’s progression and serve as a roadmap for similar initiatives in other diseases Could…

June 15, 2020 Parkinson’s disease symposium and advocate meeting go virtual for 2020

GRAND RAPIDS, Mich. (June 15, 2020) — For the first time, Grand Challenges in Parkinson’s Disease and Rallying to the Challenge, Van Andel Institute’s flagship…

February 13, 2020 $4.5 million co-funding agreement for Parkinson’s research announced

NOTE: This release was originally published by The Cure Parkinson’s Trust LONDON (Feb. 13, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute…

January 30, 2019 Australian Government invests in innovative genomic testing in Linked Clinical Trials program

This story originally appeared on The Cure Parkinson’s Trust website. To learn more, click here.   It was announced today that the Australian Parkinson's…